AZ Makes Fresh mRNA Move With Ethris Respiratory Pact

 
• By Kevin Grogan

A long-time player in messenger RNA through its partnership with Moderna Therapeutics, AstraZeneca has paid €25m upfront to a German biotech to find targets for investigation in asthma, COPD and idiopathic pulmonary fibrosis.

Attractive senior woman savoring the moment standing with her eyes closed and head tilted back with a serene expression as she clasps her chest with her hands
And Breathe: AstraZeneca has boosted its early-stage respiratory pipeline • Source: Shutterstock

More from Deals

More from Business